Adverse events and reporting mechanisms for seasonal malaria chemoprevention: Insights from a survey in Karamoja region, Uganda

Authors: Musa Odongo, Richard Kajubi, Anthony Nuwa, Craig Bonnington, Kevin Baker, Maureen Nakirunda, Tonny Kyagulanyi, Jane Nabakooza, David Salandini, Jimmy Opigo, Godfrey Magumba, Jane Achan, Damian Rutazaana, Denis Rubahika, James Tibenderana

Reporting mechanisms for adverse events were well known by caregivers and adverse events were adequately reported.

Seasonal malaria chemoprevention (SMC) is recommended by the World Health Organization (WHO) for children at risk of severe malaria in areas with highly seasonal transmission. Ensuring effective reporting and management of adverse events (AEs) is crucial for ensuring safety and sustaining the acceptability of SMC. This study assessed the frequency of AEs following administration of sulfadoxine-pyrimethamine and amodiaquine (SPAQ) for SMC, caregiver knowledge of AEs and the frequency of reporting of AEs in Karamoja region, Uganda.

This poster was presented at the Multilateral Initiative on Malaria (MIM) Society's 8th Pan-African Malaria Conference.